Can Hyperbaric Oxygen Therapy Boost Cancer Immunotherapy?
Possibly. This 2023 review found that, mostly in animal studies, hyperbaric oxygen therapy may help immunotherapy by changing the tumor environment in several ways. HBO relieves tumor hypoxia, breaks down barriers that block immune cells, and in a mouse study improved the immune response to a PD-1 antibody.
Cancer immunotherapy helps your immune system fight tumors. But tumors create hostile environments that block immune cells from doing their job. This review explores how hyperbaric oxygen therapy can change that environment and help immunotherapy work better.
What the Research Shows
- Tumor penetration: HBO combined with Doxil achieved a 91% tumor inhibition rate
- T cell access: HBO reduces regulatory T cells in tumors and increases killer T cell infiltration
- Barrier breakdown: HBO depletes the dense tissue matrix (ECM) that blocks immune cells
- Oxygen delivery: HBO down-regulates HIF1α, a protein that helps tumors resist treatment
- Gene effects: In cultured human blood vessel lining cells, HBO switched up to 8,100 genes up or down within 24 hours
Dr. Kumar’s Take
This review pulls together mostly preclinical research suggesting that HBO might help immunotherapy in several ways. The authors are clear that studies combining HBO and immunotherapy are few, and that there is still a long way to go before this reaches clinical practice. In theory, HBO could attack the problem from several angles at once. It adds oxygen to starved tumor tissues. It breaks down the physical barriers that keep drugs and immune cells out. And it changes the chemical signals that tumors use to hide from the immune system.
The proven track record is with radiotherapy and photodynamic therapy, where hyperbaric oxygen has been shown to raise tumor sensitivity. Studies pairing it with immunotherapy are still few, so the PD-1 combination is a case this review builds rather than a result it reports. However, the review also raises an important caution about reactive oxygen species. HBO produces these molecules, which can either help or hurt depending on the amount. This tells me that dosing will be critical to get right.
How Tumors Block Immunotherapy
Tumors create low-oxygen environments that work against treatment in several ways:
Immune cell suppression: Low oxygen triggers a protein called HIF1α. This protein increases PD-L1 on tumor cells, which blocks T cells from attacking. It also reduces the ability of immune cells to present tumor signals to other immune cells.
Physical barriers: Hypoxia causes collagen buildup around tumors. In lab studies, the tissue matrix made by oxygen-starved fibroblasts was 3 times stiffer than matrix made by fibroblasts with normal oxygen. This dense tissue physically prevents immune cells and antibody drugs from reaching the tumor core.
Immune environment shift: Low oxygen recruits suppressor cells that protect the tumor. It also reduces the cells that would normally attack cancer.
How HBO Changes the Tumor Environment
Hyperbaric oxygen therapy addresses these problems through several pathways:
Oxygen delivery: HBO floods tissues with oxygen that dissolves directly in blood plasma. This reaches areas that red blood cells cannot access, including deep inside tumors.
HIF1α reduction: By relieving hypoxia, HBO causes HIF1α to break down. This reduces PD-L1 expression and reverses many of the tumor’s protective mechanisms.
Barrier breakdown: HBO reduces collagen fibers, fibronectin, and other dense tissue components. This opens paths for drugs and immune cells to enter the tumor.
Immune activation: HBO increases the proportion of M1 and M2 macrophages and effector memory T cells in the tumor environment. It reduces regulatory T cells that suppress immune responses.
Practical HBO Protocols
The review describes the dosing most commonly used in studies:
- Pressure: Most studies used 2.5 atmospheres with 100% oxygen
- Duration: 90 minutes per session
- Frequency: Daily treatment for 3 to 7 days
- Best protocol unknown: The authors say the best dose and exposure mode of HBO for cancer immunotherapy still need further study
Important Cautions
HBO produces reactive oxygen species (ROS). High levels of ROS can kill cancer cells, but they can also cause problems:
- ROS may stabilize HIF1α in some cases, working against treatment goals
- In one glioma study, HBO actually promoted tumor growth by affecting T cell development
- The balance of ROS effects depends on dose and tumor type
Practical Takeaways
- HBO shows promise as an addition to cancer immunotherapy
- Evidence for pairing HBO with PD-1 antibodies comes from mouse studies so far
- Timing and dose matter significantly for outcomes
- Talk to your oncologist about whether HBO might help your specific situation
- Do not pursue HBO as a standalone cancer treatment
Related Studies and Research
- Hypoxia metabolism in ageing
- Hypoxia and inflammation: two sides of the same coin
- Does Training While Breathing Extra Oxygen Improve Fitness?
- Effects of Hyperbaric Oxygen Therapy on Mitochondrial Respiration and Physical Performance in Middle-Aged Athletes: A Blinded, Randomized Controlled Trial
FAQs
How does HBO help immunotherapy work better?
HBO relieves tumor hypoxia, which removes several barriers to immunotherapy. It reduces the PD-L1 protein that tumors use to hide from immune cells. It breaks down dense tissue that blocks drug and cell penetration. And in animal studies it reduced regulatory T cells and increased T cell infiltration into tumors.
Is HBO a cancer treatment by itself?
No. HBO has not been shown clinically to affect cancer in any significant way by itself. The authors take that as a strong suggestion that it would need to be combined with other treatments, such as immunotherapy, and that combination is still being studied.
What is the typical HBO treatment protocol for cancer?
Most studies used 100% oxygen at 2.5 atmospheres pressure for 90 minutes per session. Treatment typically lasted 3 to 7 days. The authors say the best dose and exposure mode for supporting immunotherapy still need further study.
Are there risks to combining HBO with cancer treatment?
Yes. HBO produces reactive oxygen species that have mixed effects. Some studies showed benefits, while at least one glioma study showed HBO actually promoted tumor growth by affecting immune cell development. Medical supervision is essential.
Bottom Line
This 2023 review suggests that hyperbaric oxygen therapy might enhance cancer immunotherapy by changing the tumor microenvironment, but the evidence comes mostly from preclinical models and studies of the combination are few. In those studies, HBO relieved the oxygen starvation that helps tumors resist treatment, broke down physical barriers that block immune cells, and reduced immune-suppressing regulatory T cells. Combined with the chemotherapy drug Doxil, HBO achieved a 91% tumor inhibition rate in one mouse study. While the evidence is promising, the dual effects of reactive oxygen species production require careful attention to dosing and timing. In the authors’ words, there is still a long way to go before this can be applied in clinical practice, so HBO for immunotherapy remains a research question.
